S A M Fenton1, T Neogi2, D Dunlop3, M Nevitt4, M Doherty5, J L Duda6, R Klocke7, A Abhishek8, A Rushton9, W Zhang10, C E Lewis11, J Torner12, G Kitas13, D K White14. 1. School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, England, UK; Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, England, UK. Electronic address: s.a.m.fenton@bham.ac.uk. 2. Clinical Epidemiology Research and Training Unit, Boston University Medical Center, Boston, MA, USA. Electronic address: tneogi@bu.edu. 3. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: ddunlop@northwestern.edu. 4. University of California San Francisco, San Francisco, CA, USA. Electronic address: MNevitt@psg.ucsf.edu. 5. Faculty of Medicine and Health Sciences, University of Nottingham, England, UK. Electronic address: Michael.Doherty@nottingham.ac.uk. 6. School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, England, UK. Electronic address: j.l.duda@bham.ac.uk. 7. Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, England, UK. Electronic address: Rainer.Klocke@dgh.nhs.uk. 8. Faculty of Medicine and Health Sciences, University of Nottingham, England, UK. Electronic address: docabhishek@gmail.com. 9. School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, England, UK. Electronic address: A.B.Rushton@bham.ac.uk. 10. Faculty of Medicine and Health Sciences, University of Nottingham, England, UK. Electronic address: Weiya.Zhang@nottingham.ac.uk. 11. University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: celewis@uabmc.edu. 12. University of Iowa, Iowa City, IA, USA. Electronic address: james-torner@uiowa.edu. 13. School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, England, UK; Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, England, UK. Electronic address: kitas@dgh.nhs.uk. 14. Department of Physical Therapy, University of Delaware, Newark, DE, USA. Electronic address: dkw@udel.edu.
Abstract
OBJECTIVE: Knee osteoarthritis (OA) is a risk factor for a decline in gait speed. Daily walking reduces the risk of developing slow gait speed and future persistent functional limitation. However, the protective role of walking intensity is unclear. We investigated the association of substituting time spent not walking, with walking at light and moderate-to-vigorous intensities for incident slow gait over 2-years, among people with or at high risk of knee OA. METHOD: We used baseline and 2-year follow-up data from the Multicenter Osteoarthritis (MOST) study (n = 1731) and the Osteoarthritis Initiative (OAI, n = 1925). Daily walking intensity was objectively assessed using accelerometer-enabled devices, and classified as; not walking (<1 steps/min), very-light (1-49 steps/min), light (50-100 steps/min), and moderate-to-vigorous (>100 steps/min). We defined slow gait during a 20-m walk, as <1 m/s and <1.2 m/s. Isotemporal substitution evaluated time-substitution effects on incident slow gait outcomes at 2-years. RESULTS: Replacing 20 min/day of not walking with walking at a moderate-to-vigorous intensity, demonstrated small to moderate reductions in the risk of developing a gait speed <1.0 m/s (Relative Risk [95% confidence interval (CI)]; MOST = 0.51 [0.27, 0.98], OAI = 0.21 [0.04, 0.98]), and <1.2 m/s (MOST = 0.73 [0.53, 1.00], OAI = 0.65 [0.36, 1.18]). However, only risk reductions for <1.0 m/s met statistical significance. Replacing not walking with very-light or light intensity walking was not associated with the risk of developing slow gait outcomes. CONCLUSION: When possible, walking at a moderate-to-vigorous intensity (>100 steps/min) may be best recommended in order to reduce the risk of developing critical slow gait speed among people with, or at high risk of knee OA.
OBJECTIVE:Knee osteoarthritis (OA) is a risk factor for a decline in gait speed. Daily walking reduces the risk of developing slow gait speed and future persistent functional limitation. However, the protective role of walking intensity is unclear. We investigated the association of substituting time spent not walking, with walking at light and moderate-to-vigorous intensities for incident slow gait over 2-years, among people with or at high risk of knee OA. METHOD: We used baseline and 2-year follow-up data from the Multicenter Osteoarthritis (MOST) study (n = 1731) and the Osteoarthritis Initiative (OAI, n = 1925). Daily walking intensity was objectively assessed using accelerometer-enabled devices, and classified as; not walking (<1 steps/min), very-light (1-49 steps/min), light (50-100 steps/min), and moderate-to-vigorous (>100 steps/min). We defined slow gait during a 20-m walk, as <1 m/s and <1.2 m/s. Isotemporal substitution evaluated time-substitution effects on incident slow gait outcomes at 2-years. RESULTS: Replacing 20 min/day of not walking with walking at a moderate-to-vigorous intensity, demonstrated small to moderate reductions in the risk of developing a gait speed <1.0 m/s (Relative Risk [95% confidence interval (CI)]; MOST = 0.51 [0.27, 0.98], OAI = 0.21 [0.04, 0.98]), and <1.2 m/s (MOST = 0.73 [0.53, 1.00], OAI = 0.65 [0.36, 1.18]). However, only risk reductions for <1.0 m/s met statistical significance. Replacing not walking with very-light or light intensity walking was not associated with the risk of developing slow gait outcomes. CONCLUSION: When possible, walking at a moderate-to-vigorous intensity (>100 steps/min) may be best recommended in order to reduce the risk of developing critical slow gait speed among people with, or at high risk of knee OA.
Authors: Søren Brage; Niels Wedderkopp; Paul W Franks; Lars Bo Andersen; Karsten Froberg Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Catrine Tudor-Locke; Sarah M Camhi; Claudia Leonardi; William D Johnson; Peter T Katzmarzyk; Conrad P Earnest; Timothy S Church Journal: Prev Med Date: 2011-06-25 Impact factor: 4.018
Authors: Feitong Wu; Karen Wills; Laura L Laslett; Brian Oldenburg; Graeme Jones; Tania Winzenberg Journal: J Bone Miner Res Date: 2016-11-25 Impact factor: 6.741
Authors: Kristin C Brown; Heather M Hanson; Flavio Firmani; Danmei Liu; Megan M McAllister; Khalil Merali; Joseph H Puyat; Maureen C Ashe Journal: Gerontol Geriatr Med Date: 2015-12-04
Authors: Caroline M Lisee; Alexander H K Montoye; Noble F Lewallen; Mayrena Hernandez; David R Bell; Christopher M Kuenze Journal: J Athl Train Date: 2020-09-01 Impact factor: 2.860
Authors: Hiral Master; Louise M Thoma; Dorothy D Dunlop; Meredith B Christiansen; Dana Voinier; Daniel K White Journal: J Rheumatol Date: 2021-02-01 Impact factor: 5.346
Authors: Hiral Master; Louise M Thoma; Tuhina Neogi; Dorothy D Dunlop; Michael LaValley; Meredith B Christiansen; Dana Voinier; Daniel K White Journal: Arch Phys Med Rehabil Date: 2021-06-24 Impact factor: 4.060